Stellate Ganglion Block in Complex Regional Pain Syndrome
ConditionStellate Ganglion Block
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAnkara City Hospital Bilkent
About this trial
The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.
Eligibility criteria
Qualifiers
Volunteer male and female patients aged 18-75
Diagnosed with Complex Regional Pain Syndrome according to the IASP 2012 Diagnostic Criteria
Patient's pain level must be VAS >4
Disqualifiers
Presence of existing neurological diseases other than rheumatic diseases and stroke
General impairment
Conditions that would constitute a contraindication to application, such as an open wound or sensory deficit in the application area
Presence of active infection
Trial design
Treatments tested in this trial
- Stellate Ganglion Block
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov